Value creation in the pharmaceutical industry : the critical path to innovation

Bibliographic Details
Other Authors: Gassmann, Oliver , 1967- (Editor), Hinder, Markus (Editor), Schuhmacher, Alexander (Editor)
Format: Book
Language:English
Published: Weinheim, Germany : Wiley-VCH c2016
Subjects:

MARC

LEADER 00000cam a2200000 7i4500
001 0000091742
005 20200518093000.0
008 170530s2016 gw eng
020 |a 3527339132 
020 |a 3527693408 
020 |a 3527693416 
020 |a 3527693432 
020 |a 9783527339136 (Print) 
020 |a 9783527693405 (eBook) 
020 |a 9783527693412 (ePub) 
020 |a 9783527693429 (Mobi) 
020 |a 9783527693436 (ePDF) 
040 |a UniSZA   |e rda 
050 0 0 |a HD9665.5   |b .V35 2016 
090 0 0 |a HD9665.5   |b .V35 2016 
245 0 0 |a Value creation in the pharmaceutical industry :   |b the critical path to innovation   |c edited by Alexander Schuhmacher, Markus Hinder and Oliver Gassmann 
264 1 |a Weinheim, Germany :   |b Wiley-VCH   |c c2016 
300 |a xxii, 485 pages :   |b illustration ;   |c 25 cm. 
336 |a text  |2 rdacontent 
337 |a unmediated  |2 rdamedia 
338 |a volume  |2 rdacarrier 
504 |a Includes bibliographical references and index 
505 0 |a 1. Introduction to the book -- 2. Global epidemiological developments -- 3. The value of pharmaceutical innovation: concepts and assessment -- 4. A review of the pharmaceuticalr&d efficiency: costs, timelines, and probabilities -- 5. Financing pharmaceutical innovation -- 6. Challenges and options for drug discovery -- 7. Translational medicine: enabling the proof of concepts -- 8. Preclinical safety and risk assessment -- 9. Developing commercial solutions for therapeutic proteins -- 10. The evolution of clinical development: from technical success to clinical value creation -- 11. Translational development -- 12. Forty years of innovation in biopharmaceuticals : will the next 40 years be as revolutionary? -- 13. Vaccines: where inertia, innovation, and revolution create value, simultaneously and quietly -- 14. The patient-centric pharma company: evolution, reboot, or revolution? -- 15. The pharmaceutical industry is opening its r&d boundaries 
650 0 |a Pharmaceutical industry   |x Technological innovations 
700 1 |a Gassmann, Oliver ,   |d 1967- ,   |e editor 
700 1 |a Hinder, Markus ,   |e editor 
700 1 |a Schuhmacher, Alexander ,   |e editor 
999 |a 1000169226   |b Book   |c OPEN SHELF (30 DAYS)   |e Tembila Campus